This trial is testing a new tibial nerve stimulator to see if it is safe and effective in treating people with urgency urinary incontinence.
0 Primary · 0 Secondary · Reporting Duration: 3, 6, and 12 Months
Experimental Treatment
225 Total Participants · 2 Treatment Groups
Primary Treatment: INTIBIA Therapeutic · No Placebo Group · N/A
Age 22 - 80 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: